Oncology Medical News about factor V Leiden

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Portal, splenic and mesenteric vein thrombosis in a patient double heterozygous for factor V Leiden and prothrombin G20210A mutation
Blood Coagulation & Fibrinolysis, 11/03/09

Grouzi E et al. – The authors conclude that all patients presenting with unexplained PSMVT should be investigated for the presence of a hypercoagulable state. Anticoagulation should be considered in all patients with this diagnosis and should be a lifelong therapy in those with an underlying thrombophilia.

<< Previous
Intratumoral Cytokines and Tumor Cell Biology Determine...

Next >>
Acquired factor VIII inhibitors: case reports of paclitaxel and...

The prevalence of factor V Leiden (G1691A), prothrombin G20210A and methylenetetrahydrofolate reductase C677T mutations in Jordanian patients with [beta]-thalassemia major
Blood Coagulation & Fibrinolysis, 11/03/09 Relevance Score: 81%

Livedoid vasculiltis associated with a double heterozygous Factor V Leiden and prothrombin G20210A gene mutations
Clinical and Experimental Dermatology, 10/08/09 Relevance Score: 80%

Prevalence of factor V Leiden and prothrombin G20210A mutation in a large French population selected for nonthrombotic history: geographical and age distribution
Blood Coagulation & Fibrinolysis, 10/05/09 Relevance Score: 79%

Microparticles in deep venous thrombosis, antiphospholipid syndrome and Factor V Leiden
Platelets, 10/02/09 Relevance Score: 78%

Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms
Blood, 11/12/09 Relevance Score: 67%